Wed, Aug 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Systemic Alpha combines strategies for new fund launch in January

Thursday, December 22, 2011

amb
Peter Kambolin
Bailey McCann, Opalesque New York

Systemic Alpha Management, an established commodities-focused asset manager based in New York, is combining its trading strategies into a single product. In January, Systemic Alpha will launch its first multi-strategy CTA fund, the Systemic Alpha Multi-Strategy Futures Fund (SAMSFF).

I spoke with Systemic Alpha’s CEO Peter Kambolin about the new fund and how the current high volatility market environment is helping them achieve higher returns.

Systemic Alpha created SAMSFF by combining four of its trading strategies to build a low volatility, low correlation product for clients who are looking for a lower risk investment option in CTAs. The fund combines mean-reversing, market-neutral and directional trading strategies - all of which have been in use at Systemic Alpha since 2004.

For the past eight years, Systemic Alpha has been building a track-record of trading market neutral, absolute return strategies through its flagship product. But, unpredictable market conditions such as the Japan earthquake earlier this year caused the flagship fund to run negative for the first time in its history. This led Kambolin and his colleagues to develop the new product which will allow them to apply a mix of strategies as the markets fluctuate.

"There are a variety of positives with this fund; using multiple, tested ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner